# Lytix Biopharma ASA (LYTIX.OL): MoatMap facts

As of 17 Oct 2026. Research data, not investment advice.

As of 17 Oct 2026, MoatMap's StockRank for Lytix Biopharma ASA (LYTIX.OL) is 9/100, ranked against 24,000+ stocks in 35 markets (Quality 24, Value 24, Momentum 34, each scored against its sector).

- StockRank: 9/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 24, Value 24, Momentum 34: each a 0-100 percentile within the stock's sector.
- Position: #24,373 overall, #2,315 in Healthcare.
- Listing: Norway, OSL; Healthcare / Biotechnology.
- Last close: 7.8 NOK on 15 Oct 2026.
- Insider filings, last 180 days: directors bought USD 11K.

Source: https://moatmap.ai/stock/LYTIX.OL
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker